학술논문
Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial
Document Type
Article
Author
Source
In European Urology May 2022 81(5):515-522
Subject
Language
ISSN
0302-2838